3,4-dihydro-2h-pyrimido[1,2-b][1,2]benzothiazole (CHEM142825)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-08-17 21:27:22 UTC | ||||||||
| Update Date | 2026-08-17 21:27:22 UTC | ||||||||
| Accession Number | CHEM142825 | ||||||||
| Identification | |||||||||
| Common Name | 3,4-dihydro-2h-pyrimido[1,2-b][1,2]benzothiazole | ||||||||
| Class | Small Molecule | ||||||||
| Description | 3,4-dihydro-2h-pyrimido[1,2-b][1,2]benzothiazole belongs to the benzothiazoles, a class of organoheterocyclic compounds within the organic compounds. This compound has the chemical formula C10H10N2S and an average molecular weight of 190.27 g/mol. In biological contexts, it functions as an antioxidant (PMC7397168) and an analgesic (PMC7927091). | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C10H10N2S | ||||||||
| Average Molecular Mass | 190.270 g/mol | ||||||||
| Monoisotopic Mass | 190.056 g/mol | ||||||||
| CAS Registry Number | Not Available | ||||||||
| IUPAC Name | 3,4-dihydro-2H-pyrimido[1,2-b][1,2]benzothiazole | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | Not Available | ||||||||
| InChI Identifier | InChI=1S/C10H10N2S/c1-2-5-9-8(4-1)10-11-6-3-7-12(10)13-9/h1-2,4-5H,3,6-7H2 | ||||||||
| InChI Key | GOODELVXTBGKNR-UHFFFAOYSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | |||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
